BTRL was founded in August of 2006 with the overall mission to provide viable solutions to the treatment of degenerative diseases, focusing on cardiovascular and orthopedic systems. Read More
Recent News

Dr. Dan Simionescu received the title of Doctor Honoris Causa from the University of Medicine and Pharmacy in Targu-Mures, Romania. The event took place on December 14, 2017 in the historical Senate Hall of the University in the presence of numerous representatives of academia, clinical medicine and other special guests.

In his speech, Professor Dr. Leonard Azamfirei, the University President and Rector pointed out that the title of Doctor Honoris Causa “represents the highest honorary title that a university can give to someone" and is given to "individuals who have over time, demonstrated real and quantifiable involvement in the academic life of our university and has decisively contributed to the prestige of our university”.

      

"Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy," edited by Dr. Simionescu, has been accepted for indexing in in the Book Citation Index in the Web of Science™ Core Collection (BKCI). The BKCI is the world’s leading citation index with multidisciplinary content from the top tier publications. To learn more about BKCI, please click here.


Drs. Dan and Agneta Simionescu have been invited to speak at the 50th celebration of the first heart transplant in Cape Town, South Africa. This will be a worldwide celebration of “courage and innovation." Please click here to view the conference flyer.


More News   Quick Links
 

 Clemson Bioengineering